TechnoPhage S.A. announces spin-off of T-Oncology AG

TechnoPhage S.A. announces spin-off of T-Oncology AG

TechnoPhage announced the spin-off of T-Oncology AG, which will focus on the development of Antibody Drug Conjugates (ADCs), based on the proprietary Small Domain Antibodies platform (TechnoBodies), for the treatment of cancer. TechnoBodies technology has been...